Advertisement
UK markets open in 1 hour 44 minutes
  • NIKKEI 225

    38,741.97
    +505.90 (+1.32%)
     
  • HANG SENG

    18,449.74
    -128.56 (-0.69%)
     
  • CRUDE OIL

    78.60
    +0.12 (+0.15%)
     
  • GOLD FUTURES

    2,330.80
    -0.40 (-0.02%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • Bitcoin GBP

    50,517.85
    -508.75 (-1.00%)
     
  • CMC Crypto 200

    1,364.59
    +51.96 (+3.96%)
     
  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     
  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

Why Cara Therapeutics Shot Higher Today

Why Cara Therapeutics Shot Higher Today

Cara Therapeutics (NASDAQ: CARA) was a hot stock on Tuesday. One of the formerly clinical-stage biotech's drug candidates won FDA approval, and investors reacted in the usual manner. The biotech company's most promising drug, Korsuva --- developed with Switzerland-based Vifor Pharma -- addresses this medical challenge sufficiently to win that all-important FDA approval.